Skip to Content

BlackRock LifePath® Index 2050 Inv A LIPAX

Analyst rating as of
NAV / 1-Day Return
18.23  /  2.53 %
Total Assets
5.2 Bil
Adj. Expense Ratio
0.390%
Expense Ratio
0.390%
Fee Level
Low
Longest Manager Tenure
10.96 years
Category
Target-Date 2050
Investment Style
Large Blend
Credit Quality / Interest Rate Sensitivity
High / Moderate
Status
Open
TTM Yield
2.03%
Turnover
6%
Premium

Morningstar’s Analysis

Will LIPAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A topnotch target-date series.

Summary

| |

The BlackRock LifePath Index target-date series of funds features an innovative team with topnotch resources. It continues to earn a Morningstar Analyst Rating of Gold for its cheapest share classes and Silver for its more expensive ones.

Unlock our full analysis with Morningstar Premium